Fig. 5From: Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axisEvodiamine inhibits H1975 tumor xenografts tumor growth by downregulation of MUC1-C. a The body weight of evodiamine-treated mice does not change compared to untreated animals. b-d Verifying the effect of evodiamine in vivo, shows that compared with the controls, tumor growth exhibits a suppressive trend starting at day 15 in the evodiamine-treated mice. e and f Western blot analysis shows that MUC1-C downregulation after evodiamine treatmentBack to article page